The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
49 reports and counting
Colossal Biosciences Raises $120M in Series
Colossal Biosciences, a Biotech company based in Austin, TX, has raised $120M in Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.
Colossal Biosciences raises $120M Series at $800M valuation
Colossal Biosciences raises $120M in Series at $800M valuation. Working on de-extinction of species including mammoths and dodos...
Colossal Biosciences raises $200M Series C at $10.2B valuation
Colossal Biosciences raises $200M in Series C at $10.2B valuation. De-extinction and genetic engineering...
Colossal Biosciences raises $120M Growth at $10.2B valuation
Colossal Biosciences raises $120M in Growth at $10.2B valuation. De-extinction company using genetic engineering to revive extinct species like mammoths...
Treeline Biosciences Raises $200M in Series A
Treeline Biosciences, a HealthTech company based in San Diego, CA, has raised $200M in Series A from multiple investors.
Serán Bioscience Raises $200M in Venture
Serán Bioscience, a Biotech company based in Bend, OR, has raised $200M in Venture at a $900M valuation led by Foresite Capital, OrbiMed.
Retro Biosciences Raises $1B in Seed
Retro Biosciences, a HealthTech company based in San Francisco, CA, has raised $1B in Seed led by Sandro Salsano.
Syndeio Biosciences Raises $90M in Series
Syndeio Biosciences, a Biotech company based in Indianapolis, IN, has raised $90M in Series at a $450M valuation led by Eli Lilly and Company, ARCH Venture Partners.
Ollin Biosciences Raises $100M in Series A
Ollin Biosciences, a Biotech company based in Austin, TX, has raised $100M in Series A at a $500M valuation led by Deerfield Management, ARCH Venture Partners.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.